Stay updated with breaking news from Mikayla Olsten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In clinical trials, Tzield delayed progression to full-blown diabetes by a little over two years. But the benefits have lasted much longer in some of the study participants.
A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.
A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of life-saving insulin for people with diabetes.
A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of lifesaving insulin for people with diabetes.
A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.